Enanta Pharmaceuticals, Inc. (ENTA)
NASDAQ: ENTA · IEX Real-Time Price · USD
13.32
+0.09 (0.68%)
At close: Apr 19, 2024, 4:00 PM
13.30
-0.02 (-0.15%)
After-hours: Apr 19, 2024, 6:28 PM EDT
Enanta Pharmaceuticals Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for ENTA stock have an average target of 19.33, with a low estimate of 11 and a high estimate of 28. The average target predicts an increase of 45.12% from the current stock price of 13.32.
Analyst Consensus: Hold
* Price targets were last updated on Feb 8, 2024.
Analyst Ratings
The average analyst rating for ENTA stock from 6 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Hold | 5 | 5 | 5 | 4 | 4 | 3 |
| Sell | 0 | 0 | 0 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 8 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Sell Maintains $12 → $11 | Sell | Maintains | $12 → $11 | -17.42% | Feb 8, 2024 |
| Oppenheimer | Oppenheimer | Hold Maintains $25 → $21 | Hold | Maintains | $25 → $21 | +57.66% | Nov 22, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $30 → $28 | Strong Buy | Maintains | $30 → $28 | +110.21% | Nov 21, 2023 |
| JMP Securities | JMP Securities | Buy Maintains $42 → $23 | Buy | Maintains | $42 → $23 | +72.67% | Nov 21, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $48 → $30 | Strong Buy | Maintains | $48 → $30 | +125.23% | Oct 23, 2023 |
Financial Forecast
Revenue This Year
69.17M
from 79.20M
Decreased by -12.66%
Revenue Next Year
76.42M
from 69.17M
Increased by 10.48%
EPS This Year
-5.19
from -6.38
EPS Next Year
-4.76
from -5.19
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 76.2M | 117.5M | 122.8M | 76.7M | 88.2M |
| Avg | 69.2M | 76.4M | 76.6M | 68.7M | 72.7M |
| Low | 57.8M | 49.0M | 25.5M | 60.5M | 57.5M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -3.8% | 69.9% | 60.6% | 0.1% | 28.4% |
| Avg | -12.7% | 10.5% | 0.2% | -10.3% | 5.9% |
| Low | -27.0% | -29.2% | -66.7% | -21.0% | -16.4% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -4.57 | -3.52 | -2.05 | -3.30 | -3.23 |
| Avg | -5.19 | -4.76 | -4.13 | -3.20 | -3.14 |
| Low | -6.42 | -6.56 | -6.02 | -3.08 | -3.02 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.